AlphaQuest LLC Grows Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

AlphaQuest LLC raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 255.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 871 shares of the biotechnology company’s stock after buying an additional 626 shares during the quarter. AlphaQuest LLC’s holdings in Axon Enterprise were worth $518,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Prestige Wealth Management Group LLC raised its stake in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth about $40,000. Brooklyn Investment Group purchased a new position in shares of Axon Enterprise in the third quarter worth about $41,000. Y.D. More Investments Ltd purchased a new position in shares of Axon Enterprise in the fourth quarter worth about $45,000. Finally, Planning Capital Management Corp raised its stake in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 5.9 %

Shares of AXON opened at $557.89 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The stock’s 50 day moving average is $595.56 and its two-hundred day moving average is $532.90. The firm has a market cap of $42.75 billion, a P/E ratio of 144.16, a PEG ratio of 5.17 and a beta of 1.12.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. The Goldman Sachs Group raised their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Barclays restated a “hold” rating on shares of Axon Enterprise in a research note on Monday. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Robert W. Baird lifted their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the sale, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,146 shares of company stock valued at $3,262,847. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.